Key result
Recessive DOLK mutations associate with nonsyndromic DCM in young patients via impaired alpha-dystroglycan O-mannosylation.
Why the study?
Genetic causes for autosomal recessive dilated cardiomyopathy are rarely identified despite their contribution to sudden cardiac death and heart failure in young children.
What is the genetic and metabolic basis of nonsyndromic autosomal recessive dilated cardiomyopathy in this cohort of young patients?
Observational (n=11)
Yes
What is the genetic and metabolic basis of nonsyndromic autosomal recessive dilated cardiomyopathy in this cohort of young patients?
Autosomal recessive DOLK mutations cause nonsyndromic dilated cardiomyopathy in children through a combined deficiency of protein N-glycosylation and alpha-dystroglycan O-mannosylation.
DOLK testing warrants consideration in pediatric nonsyndromic DCM; leaves open validation and therapeutic targeting of glycosylation defects.
Genetic causes for autosomal recessive forms of dilated cardiomyopathy (DCM) are only rarely identified, although they are thought to contribute considerably to sudden cardiac death and heart failure, especially in young children. Here, we describe 11 young patients (5-13 years) with a predominant presentation of dilated cardiomyopathy (DCM). Metabolic investigations showed deficient protein N-glycosylation, leading to a diagnosis of Congenital Disorders of Glycosylation (CDG). Homozygosity mapping in the consanguineous families showed a locus with two known genes in the N-glycosylation pathway. In all individuals, pathogenic mutations were identified in DOLK, encoding the dolichol kinase responsible for formation of dolichol-phosphate. Enzyme analysis in patients' fibroblasts confirmed a dolichol kinase deficiency in all families. In comparison with the generally multisystem presentation in CDG, the nonsyndromic DCM in several individuals was remarkable. Investigation of other dolichol-phosphate dependent glycosylation pathways in biopsied heart tissue indicated reduced O-mannosylation of alpha-dystroglycan with concomitant functional loss of its laminin-binding capacity, which has been linked to DCM. We thus identified a combined deficiency of protein N-glycosylation and alpha-dystroglycan O-mannosylation in patients with nonsyndromic DCM due to autosomal recessive DOLK mutations.
No takes yet. Share an insight, caveat, or question.
Lefeber et al. (2011) conducted an observational in Dilated Cardiomyopathy (DCM) (n=11). DOLK mutations vs. Healthy controls was evaluated on Genetic and biochemical etiology of dilated cardiomyopathy. Autosomal recessive mutations in the DOLK gene cause nonsyndromic dilated cardiomyopathy in young patients by impairing alpha-dystroglycan O-mannosylation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: